MedTrace Logo

Diagnostic Accuracy of SurePath™ in EUS-FNA

NCT05394129 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 89

Last updated 2024-11-29

No results posted yet for this study

Summary

It is a prospective randomized controlled study to evaluate the diagnostic accuracy of SurePath™ liquid-based cytology in endoscopic ultrasound-guided sampling.

Conditions

  • Submucosal Tumor of Gastrointestinal Tract

Interventions

DIAGNOSTIC_TEST

SurePath™

In the liquid-based cytology, a fine-needle aspirated sample is immediately inserted into a container containing a commercially available preservative solution without a separate slide-smearing procedure and immediately after the fine-needle aspiration.

Sponsors & Collaborators

  • Seoul National University Hospital

    lead OTHER

Principal Investigators

  • Han Myung Lee, M.D. · Fellowship

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-04-09
Primary Completion
2022-01-31
Completion
2023-01-30

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05394129 on ClinicalTrials.gov